3-(4-((E)-3,7-DIMETHYLOCTA-2,6-DIENYLOXY)-STYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE
Compound with spectra: 1 NMR
![3-(4-((E)-3,7-DIMETHYLOCTA-2,6-DIENYLOXY)-STYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE](/api/compound/6E6wgWUWsiC.png?ph=true&h=300&w=458 "3-(4-((E)-3,7-DIMETHYLOCTA-2,6-DIENYLOXY)-STYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE")
| SpectraBase Compound ID | 6E6wgWUWsiC |
|---|---|
| InChI | InChI=1S/C27H28N4O/c1-20(2)7-6-8-21(3)17-18-32-24-14-11-22(12-15-24)13-16-26-29-30-27-25-10-5-4-9-23(25)19-28-31(26)27/h4-5,7,9-17,19H,6,8,18H2,1-3H3/b16-13+,21-17+ |
| InChIKey | WNVUVFJHRZINBE-HDNIMXTOSA-N |
| Mol Weight | 424.55 g/mol |
| Molecular Formula | C27H28N4O |
| Exact Mass | 424.226312 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(E)-3-[4-(3-METHYLBUT-2-ENYLOXY)-STYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE
(E)-3-(4-(2',2',2'-TRIFLUOROETHOXY)-STYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE
(E)-3-(4-TRIFLUOROMETHOXYSTYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE
3-(Pyrrolidin-1'-yl)-(1,2,4)-triazolo[3,4-a]phthalazine
5-(2-chlorophenyl)-4-{[(E)-(2,3,4-trimethoxyphenyl)methylidene]amino}-4H-1,2,4-triazol-3-yl hydrosulfide
4-{[(E)-(2-chloro-5-nitrophenyl)methylidene]amino}-5-(2-methoxyphenyl)-4H-1,2,4-triazole-3-thiol
1-((E)-{[3-(2-chlorophenyl)-5-sulfanyl-4H-1,2,4-triazol-4-yl]imino}methyl)-2-naphthol
5-(2-chlorophenyl)-4-{[(E)-(2,4,5-trimethoxyphenyl)methylidene]amino}-4H-1,2,4-triazol-3-yl hydrosulfide
4-{[(E)-(2,3-dimethoxyphenyl)methylidene]amino}-5-(2-methoxyphenyl)-4H-1,2,4-triazole-3-thiol
5-(diethylamino)-2-((E)-{[3-(2-methoxyphenyl)-5-sulfanyl-4H-1,2,4-triazol-4-yl]imino}methyl)phenol
| Title | Journal or Book | Year |
|---|---|---|
| Design, Synthesis, and Biological Evaluation of New Cinnamic Derivatives as Antituberculosis Agents | Journal of Medicinal Chemistry | 2011 |